News
The Nutrition Center warns people who want to lose weight not to take medication too lightly. “It may seem easy, but do not ...
Ozempic could help with his as a study by Goldman Sachs found that the mass-adoption of GLP-1 series drugs could allow for ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
Novo Nordisk A/S’ (NYSE:NVO) executives allegedly ignored internal warnings that the company was unprepared to launch its ...
Concerns over new age weight loss, diabetes drugs ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...
The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...
"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results